Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRDL
DateTimeSourceHeadlineSymbolCompany
02/26/20249:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
02/21/20246:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
02/15/202412:15PMAllPennyStocks.comOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company SoaringNASDAQ:CRDLCardiol Therapeutics Inc
02/15/20246:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
01/24/20246:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
01/09/20246:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
12/05/20236:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
11/16/20235:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
11/01/20236:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/20/20234:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/11/20239:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/10/20235:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/26/20236:28AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/20/20239:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/19/20236:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
08/10/20234:13PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
08/09/20237:21AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
08/08/20236:38AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
06/29/202310:45AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
06/29/202310:44AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
06/27/20236:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
05/18/20233:04PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
05/15/20233:55PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
03/29/20236:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
03/29/20235:02AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CRDLCardiol Therapeutics Inc
03/07/20236:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
12/12/20226:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
11/20/20222:35AMTipRanksCardiol Therapeutics (CRDL) Receives a Rating Update from a Top AnalystNASDAQ:CRDLCardiol Therapeutics Inc
11/20/20222:15AMTipRanksCanaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)NASDAQ:CRDLCardiol Therapeutics Inc
11/14/20224:35PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CRDL